Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Aug 28, 2020 11:45am
84 Views
Post# 31469868

RE:RE:if you think Moderna and BioNtech will corner the Covid Vacc

RE:RE:if you think Moderna and BioNtech will corner the Covid VaccI have wrote before  during the spring that mRNA is a challenge because it is very unstable and easily degrades.How the heck can BionTech supply billions of doses if they need to transport them and store them at minus 70C. It will be a huge challenge for rich countries, and how about poor countries, it will be impossible for them.



Padina wrote: In the final analysis, the race belongs to the one doing it right and not the one doing it fast. Corvax in tablet form will solve all the storage issues bcos tablets r very stable at room temperature and very resistant to temperature excursion. Something good is cooking Lets keep hope alive GLTA


<< Previous
Bullboard Posts
Next >>